Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use

Williams AR(2019)Development of a cascade of care for responding to the opioid epidemic Am J Drug Alcohol Abuse 45 1-10

Nunes EV(2022)Opioid use disorder cascade of care framework design: a roadmap Subst Abuse 43 1207-1214

Bisaga A(2016)A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU AIDS 30 2227-2234

Levin FR(2020)The Influence of Co-occurring substance use on the effectiveness of opiate treatment programs according to intervention type Epidemiol Rev 42 57-78

Olfson M(2022)Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes J Subst Abuse Treat 357 j1550-91

Williams AR(2016)Opioid agonist treatment for pharmaceutical opioid dependent people Cochrane Database Syst Rev 14 1-3503

Johnson KA(2017)Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies BMJ 116 3494-6

Thomas CP(2018)Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study Ann Intern Med 321 844-1956

Reif S(2020)The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update J Addict Med 345 e5945-711

Socías ME(2021)Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration Addict Abingdon Engl 16 1-41

Williams AR(2019)Development of a cascade of care for responding to the opioid epidemic Am J Drug Alcohol Abuse 45 1-10

Nunes EV(2022)Opioid use disorder cascade of care framework design: a roadmap Subst Abuse 43 1207-1214

Bisaga A(2016)A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU AIDS 30 2227-2234

Levin FR(2020)The Influence of Co-occurring substance use on the effectiveness of opiate treatment programs according to intervention type Epidemiol Rev 42 57-78

Olfson M(2022)Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes J Subst Abuse Treat 357 j1550-91

Williams AR(2016)Opioid agonist treatment for pharmaceutical opioid dependent people Cochrane Database Syst Rev 14 1-3503

Johnson KA(2017)Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies BMJ 116 3494-6

Thomas CP(2018)Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study Ann Intern Med 321 844-1956

Reif S(2020)The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update J Addict Med 345 e5945-711

Socías ME(2021)Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration Addict Abingdon Engl 16 1-41